NHS National Generic Pharmaceuticals- Transition 2021_1

NHS National PharmaceuticalsTransition 2021_1 Offer referencenumber: CM/PHG/20/5629 Period offramework agreement: the totalmaximum duration of the frameworkagreement to be no more than 29months (14.5 months plus options toextend (at the Authority's solediscretion) for up to a further 14.5months) Potential Periods of call-offsunder the framework agreementTransition and 33 % Products: CESW 15 April 2021 to 30 September2021 (5.5 months); LSNE 15 April 2021 to 28 February2022 (10.5 months); NWLN 15 April 2021 to 30 June 2022(14.5 months); 100 % Products (All Regions): 15 April2021 to 28 February 2022 (10.5months).